ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 0194

Reproductive Health Conversations with a Primarily Hispanic Systemic Lupus Erythematosus Population: Influences and Barriers

Zarmeen Zaheer1, Martha Delgado2, Jack Rodman3, Julia Simard4, Sandy Lee5 and Leanna Wise6, 1Huntington Health, Tampa, FL, 2LAC+USC/Keck School of Medicine, Los Angeles, CA, 3University of Southern California, Los Angeles, CA, 4Department of Epidemiology & Population Health, Stanford University School of Medicine, Stanford, CA, 5University of Southern California, Walnut, CA, 6LAC+USC/Keck Medicine of USC, Pasadena, CA

Meeting: ACR Convergence 2023

Keywords: Demographics, Disparities, pregnancy, Surveys, Women's health

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Sunday, November 12, 2023

Title: (0176–0195) Healthcare Disparities in Rheumatology Poster I: Lupus

Session Type: Poster Session A

Session Time: 9:00AM-11:00AM

Background/Purpose: Systemic lupus erythematosus (SLE) is an autoimmune disease most commonly seen in women of childbearing age, with a greater burden in non-Caucasian populations. The American College of Rheumatology (ACR) published guidelines in 2020 to inform a shared decision-making process on reproductive health management between patients and their physicians. However, there is little data as to how these guidelines are experienced by patients in the “real world” setting, and specifically by Hispanic patients, who have high rates of poor SLE outcomes. Our patient survey assesses influences on and barriers to reproductive health conversations and explores how a predominantly Hispanic SLE population obtains reproductive health information.

Methods: A 28-question survey was distributed in either English or Spanish to female patients with SLE ages 18 – 50 in our outpatient urban Los Angeles rheumatology clinic. Questions focused on four areas – contraception, preconception counseling, pregnancy management, and medication safety – and were informed by the ACR guidelines. The majority of the questions were multiple choice. Patients were not required to answer all questions and branching logic was used depending on patients’ unique reproductive history. Data were presented using frequency (%) or median (IQR) and evaluated using Fisher’s exact or Wilcoxon rank sum test, as appropriate.

Results: From March 15, 2023 to May 16, 2023, 61 surveys were collected (Table 1). Response rate was 92%. 40% of patients noted that the rheumatologist was most likely to initiate a conversation about reproductive health-related topics; 31% reported that patient and rheumatologist were equally likely to initiate such a conversation, and 19% noted never having any such conversation (Table 2).86% of respondents believed that their rheumatologist had sufficient expertise to answer questions about the effect of SLE on contraception use and pregnancy planning, however, this was observed more frequently in the English survey (91%) compared to the Spanish survey (69%) (p = 0.062) (Table 3). 56% of patients identified that there were difficulties with reproductive health care discussions, most commonly noting: “I don’t think it’s safe for me to become pregnant” (19.7%), and “my lupus doctor has suggested that I talk with an OBGYN instead” (18%). Respondents noted their top three sources for reproductive health information as their rheumatologists (73.8%), the internet (32.8%), and their OBGYN (16.4%) (Table 2).

Conclusion: Our data show that most respondents of our primarily Hispanic SLE population in a safety-net clinic rely on the rheumatologist as a crucial source of reproductive health information. However, more than half reported that there were difficulties with reproductive health conversations, including patients’ perception about the safety of pregnancy, and rheumatologists deferring to OBGYNs. Furthermore, nearly 20% noted never having a reproductive health conversation with a rheumatologist. Given the above, effective interventions to improve evidence-based reproductive health conversations between Hispanic patients with SLE and rheumatologists should be investigated.

Supporting image 1

Table 1. Demographic and clinical characteristics for all 61 patient respondents

Supporting image 2

Table 2. Influences on reproductive health conversations (given the total N for this table)

Supporting image 3

Table 3. Barriers and contraception discussion by survey language group


Disclosures: Z. Zaheer: None; M. Delgado: None; J. Rodman: None; J. Simard: None; S. Lee: None; L. Wise: AstraZeneca, 6, Aurinia Pharma, 2, 6, GlaxoSmithKlein(GSK), 6.

To cite this abstract in AMA style:

Zaheer Z, Delgado M, Rodman J, Simard J, Lee S, Wise L. Reproductive Health Conversations with a Primarily Hispanic Systemic Lupus Erythematosus Population: Influences and Barriers [abstract]. Arthritis Rheumatol. 2023; 75 (suppl 9). https://acrabstracts.org/abstract/reproductive-health-conversations-with-a-primarily-hispanic-systemic-lupus-erythematosus-population-influences-and-barriers/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to ACR Convergence 2023

ACR Meeting Abstracts - https://acrabstracts.org/abstract/reproductive-health-conversations-with-a-primarily-hispanic-systemic-lupus-erythematosus-population-influences-and-barriers/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology